Published in PLoS Negl Trop Dis on November 02, 2010
Multigene families in Trypanosoma cruzi and their role in infectivity. Infect Immun (2012) 1.01
Genomic analyses, gene expression and antigenic profile of the trans-sialidase superfamily of Trypanosoma cruzi reveal an undetected level of complexity. PLoS One (2011) 0.94
The MASP family of Trypanosoma cruzi: changes in gene expression and antigenic profile during the acute phase of experimental infection. PLoS Negl Trop Dis (2012) 0.85
Transcriptome Remodeling in Trypanosoma cruzi and Human Cells during Intracellular Infection. PLoS Pathog (2016) 0.84
Selection of binding targets in parasites using phage-display and aptamer libraries in vivo and in vitro. Front Immunol (2013) 0.82
Trans-sialidase stimulates eat me response from epithelial cells. Traffic (2013) 0.80
The vasculature in chagas disease. Adv Parasitol (2011) 0.78
Prokineticin receptor identified by phage display is an entry receptor for Trypanosoma cruzi into mammalian cells. Parasitol Res (2014) 0.78
Trypanosoma cruzi infection and host lipid metabolism. Mediators Inflamm (2014) 0.78
Putting Infection Dynamics at the Heart of Chagas Disease. Trends Parasitol (2016) 0.77
Endothelial transmigration by Trypanosoma cruzi. PLoS One (2013) 0.76
Trypanosoma cruzi Binds to Cytokeratin through Conserved Peptide Motifs Found in the Laminin-G-Like Domain of the gp85/Trans-sialidase Proteins. PLoS Negl Trop Dis (2015) 0.76
A Brief View of the Surface Membrane Proteins from Trypanosoma cruzi. J Parasitol Res (2017) 0.76
Transcriptomic analysis reveals metabolic switches and surface remodeling as key processes for stage transition in Trypanosoma cruzi. PeerJ (2017) 0.75
Mechanisms of Infectivity and Evasion Derived from Microvesicles Cargo Produced by Trypanosoma cruzi. Front Cell Infect Microbiol (2016) 0.75
Secretome analysis of Trypanosoma cruzi by proteomics studies. PLoS One (2017) 0.75
Filamentous fusion phage: novel expression vectors that display cloned antigens on the virion surface. Science (1985) 10.42
The genome sequence of Trypanosoma cruzi, etiologic agent of Chagas disease. Science (2005) 7.61
Direct derivation of conditionally immortal cell lines from an H-2Kb-tsA58 transgenic mouse. Proc Natl Acad Sci U S A (1991) 5.52
Organ targeting in vivo using phage display peptide libraries. Nature (1996) 5.20
Tissue-specific microvascular endothelial cell lines from H-2K(b)-tsA58 mice for studies of angiogenesis and metastasis. Cancer Res (2003) 2.32
Introducing intermediate filaments: from discovery to disease. J Clin Invest (2009) 1.96
Biopanning and rapid analysis of selective interactive ligands. Nat Med (2001) 1.79
Next-generation phage display: integrating and comparing available molecular tools to enable cost-effective high-throughput analysis. PLoS One (2009) 1.66
The Trypanosoma cruzi-host-cell interplay: location, invasion, retention. Nat Rev Microbiol (2005) 1.60
Targeted induction of lung endothelial cell apoptosis causes emphysema-like changes in the mouse. J Biol Chem (2008) 1.44
Partial inhibition of trypomastigote entry into cultured mammalian cells by monoclonal antibodies against a surface glycoprotein of Trypanosoma cruzi. Mol Biochem Parasitol (1986) 1.37
Absence of keratin 19 in mice causes skeletal myopathy with mitochondrial and sarcolemmal reorganization. J Cell Sci (2007) 1.34
The role of the organ microenvironment in the biology and therapy of cancer metastasis. J Cell Biochem (2007) 1.28
The surface trans-sialidase family of Trypanosoma cruzi. Annu Rev Microbiol (1993) 1.26
Chagas heart disease pathogenesis: one mechanism or many? Curr Mol Med (2008) 1.26
The chronic gastrointestinal manifestations of Chagas disease. Clinics (Sao Paulo) (2009) 1.21
Elevated serum levels of epithelial cell apoptosis-specific cytokeratin 18 neoepitope m30 in critically ill patients. Shock (2004) 1.20
A Trypanosoma cruzi-secreted 80 kDa proteinase with specificity for human collagen types I and IV. Biochem J (1997) 1.17
Infection by Trypanosoma cruzi. Identification of a parasite ligand and its host cell receptor. J Biol Chem (2001) 1.09
Detection of live Trypanosoma cruzi in tissues of infected mice by using histochemical stain for beta-galactosidase. Infect Immun (1999) 1.07
Combinatorial ligand-directed lung targeting. Proc Am Thorac Soc (2009) 1.07
Trypanosoma cruzi: adhesion to the host cell and intracellular survival. IUBMB Life (2007) 1.06
An acidic component of the heterogeneous Tc-85 protein family from the surface of Trypanosoma cruzi is a laminin binding glycoprotein. Mol Biochem Parasitol (1994) 1.01
Beyond receptor expression levels: the relevance of target accessibility in ligand-directed pharmacodelivery systems. Trends Cardiovasc Med (2008) 1.00
Cloning and characterization of cytokeratins 8 and 19 in adult rat striated muscle. Interaction with the dystrophin glycoprotein complex. J Biol Chem (2004) 1.00
Targeted reduction in expression of Trypanosoma cruzi surface glycoprotein gp90 increases parasite infectivity. Infect Immun (2001) 0.98
Identification and isolation of Trypanosoma cruzi trypomastigote collagen-binding proteins: possible role in cell-parasite interaction. Parasitology (1988) 0.98
A ligand peptide motif selected from a cancer patient is a receptor-interacting site within human interleukin-11. PLoS One (2008) 0.96
Vimentin and desmin possess GlcNAc-binding lectin-like properties on cell surfaces. Glycobiology (2010) 0.96
Role of the gp85/trans-sialidase superfamily of glycoproteins in the interaction of Trypanosoma cruzi with host structures. Subcell Biochem (2008) 0.93
Trypanosoma cruzi infection induced changes in the innervation, structure and function of the murine bladder. J Urol (2005) 0.92
Elevated levels of interleukin-1beta-converting enzyme and caspase-cleaved cytokeratin-18 in acute myocardial infarction. Eur J Clin Invest (2007) 0.89
Silencing cytokeratin 18 gene inhibits intracellular replication of Trypanosoma cruzi in HeLa cells but not binding and invasion of trypanosomes. BMC Cell Biol (2008) 0.88
Polymerase chain reaction detection of Trypanosoma cruzi in Macaca fascicularis using archived tissues. Am J Trop Med Hyg (2009) 0.88
A conserved domain of the gp85/trans-sialidase family activates host cell extracellular signal-regulated kinase and facilitates Trypanosoma cruzi infection. Exp Cell Res (2006) 0.87
Expression and genome-wide distribution of the gene family encoding a 90 kDa surface glycoprotein of metacyclic trypomastigotes of Trypanosoma cruzi. Mol Biochem Parasitol (2002) 0.85
Esophageal involvement in congenital Chagas' disease. Report of a case with megaesophagus. Am J Trop Med Hyg (1984) 0.81
Major surface immunogens of Trypanosoma cruzi trypomastigotes. Mem Inst Oswaldo Cruz (1988) 0.79
Myocardial lipofuscin-laden lysosomes contain the apoptosis marker caspase-cleaved cytokeratin-18. Eur J Clin Invest (2008) 0.79
A population of multipotent CD34-positive adipose stromal cells share pericyte and mesenchymal surface markers, reside in a periendothelial location, and stabilize endothelial networks. Circ Res (2007) 4.34
Reversal of obesity by targeted ablation of adipose tissue. Nat Med (2004) 4.23
Steps toward mapping the human vasculature by phage display. Nat Med (2002) 3.82
Fingerprinting the circulating repertoire of antibodies from cancer patients. Nat Biotechnol (2002) 3.32
Genetic basis for in vivo daptomycin resistance in enterococci. N Engl J Med (2011) 3.20
Intravascular delivery of particulate systems: does geometry really matter? Pharm Res (2008) 3.13
Regulation of tumor angiogenesis by EZH2. Cancer Cell (2010) 3.10
Random peptide libraries displayed on adeno-associated virus to select for targeted gene therapy vectors. Nat Biotechnol (2003) 3.01
Cell surface expression of the stress response chaperone GRP78 enables tumor targeting by circulating ligands. Cancer Cell (2004) 2.99
Effect of interleukin-8 gene silencing with liposome-encapsulated small interfering RNA on ovarian cancer cell growth. J Natl Cancer Inst (2008) 2.40
A hybrid vector for ligand-directed tumor targeting and molecular imaging. Cell (2006) 2.20
Interleukin-6, secreted by human ovarian carcinoma cells, is a potent proangiogenic cytokine. Cancer Res (2005) 2.16
Three-dimensional tissue culture based on magnetic cell levitation. Nat Nanotechnol (2010) 2.11
Targeting the prostate for destruction through a vascular address. Proc Natl Acad Sci U S A (2002) 2.01
Display technologies: application for the discovery of drug and gene delivery agents. Adv Drug Deliv Rev (2006) 1.92
Vimentin is a novel anti-cancer therapeutic target; insights from in vitro and in vivo mice xenograft studies. PLoS One (2010) 1.87
High expression of ligands for chemokine receptor CXCR2 in alveolar epithelial neoplasia induced by oncogenic kras. Cancer Res (2006) 1.84
White adipose tissue cells are recruited by experimental tumors and promote cancer progression in mouse models. Cancer Res (2009) 1.78
Astrocytes upregulate survival genes in tumor cells and induce protection from chemotherapy. Neoplasia (2011) 1.78
Differential binding of drugs containing the NGR motif to CD13 isoforms in tumor vessels, epithelia, and myeloid cells. Cancer Res (2002) 1.76
State of the art. Cellular and molecular mechanisms of alveolar destruction in emphysema: an evolutionary perspective. Proc Am Thorac Soc (2006) 1.75
A peptidomimetic targeting white fat causes weight loss and improved insulin resistance in obese monkeys. Sci Transl Med (2011) 1.74
Design and validation of a bifunctional ligand display system for receptor targeting. Chem Biol (2004) 1.73
Networks of gold nanoparticles and bacteriophage as biological sensors and cell-targeting agents. Proc Natl Acad Sci U S A (2006) 1.73
SPARC regulates extracellular matrix organization through its modulation of integrin-linked kinase activity. J Biol Chem (2005) 1.70
Coronary microvascular pericytes are the cellular target of sunitinib malate-induced cardiotoxicity. Sci Transl Med (2013) 1.69
Phase II presurgical feasibility study of bevacizumab in untreated patients with metastatic renal cell carcinoma. J Clin Oncol (2009) 1.67
Next-generation phage display: integrating and comparing available molecular tools to enable cost-effective high-throughput analysis. PLoS One (2009) 1.66
Synchronous selection of homing peptides for multiple tissues by in vivo phage display. FASEB J (2006) 1.63
Ethics guidelines for research with the recently dead. Nat Med (2005) 1.56
Combinatorial screenings in patients: the interleukin-11 receptor alpha as a candidate target in the progression of human prostate cancer. Cancer Res (2004) 1.56
Impaired angiogenesis in aminopeptidase N-null mice. Proc Natl Acad Sci U S A (2007) 1.53
Platinum-based chemotherapy for variant castrate-resistant prostate cancer. Clin Cancer Res (2013) 1.53
Novel function of alternatively activated macrophages: stabilin-1-mediated clearance of SPARC. J Immunol (2006) 1.53
Upregulated stromal EGFR and vascular remodeling in mouse xenograft models of angiogenesis inhibitor-resistant human lung adenocarcinoma. J Clin Invest (2011) 1.52
A previously unrecognized protein-protein interaction between TWEAK and CD163: potential biological implications. J Immunol (2007) 1.52
Aminopeptidase N inhibitors and SARS. Lancet (2003) 1.47
Biobehavioral influences on matrix metalloproteinase expression in ovarian carcinoma. Clin Cancer Res (2008) 1.46
The neovasculature homing motif NGR: more than meets the eye. Blood (2008) 1.46
Vascular targeting: recent advances and therapeutic perspectives. Trends Cardiovasc Med (2006) 1.44
Targeted induction of lung endothelial cell apoptosis causes emphysema-like changes in the mouse. J Biol Chem (2008) 1.44
In vitro selection of RNA aptamers that bind to cell adhesion receptors of Trypanosoma cruzi and inhibit cell invasion. J Biol Chem (2002) 1.37
EphA2 immunoconjugate as molecularly targeted chemotherapy for ovarian carcinoma. J Natl Cancer Inst (2009) 1.37
Molecular PET imaging of HSV1-tk reporter gene expression using [18F]FEAU. Nat Protoc (2007) 1.35
Launching a novel preclinical infrastructure: comparative oncology trials consortium directed therapeutic targeting of TNFalpha to cancer vasculature. PLoS One (2009) 1.33
A physical sciences network characterization of non-tumorigenic and metastatic cells. Sci Rep (2013) 1.33
Targeted therapy of orthotopic human lung cancer by combined vascular endothelial growth factor and epidermal growth factor receptor signaling blockade. Mol Cancer Ther (2007) 1.32
The role of the organ microenvironment in the biology and therapy of cancer metastasis. J Cell Biochem (2007) 1.28
Trypanosoma cruzi: parasite shed vesicles increase heart parasitism and generate an intense inflammatory response. Microbes Infect (2008) 1.28
Aminopeptidase A is a functional target in angiogenic blood vessels. Cancer Cell (2004) 1.28
Design and construction of targeted AAVP vectors for mammalian cell transduction. Nat Protoc (2007) 1.27
Probing the structural and molecular diversity of tumor vasculature. Trends Mol Med (2002) 1.26
Impact of vessel maturation on antiangiogenic therapy in ovarian cancer. Am J Obstet Gynecol (2008) 1.25
Cardiomyocyte PDGFR-beta signaling is an essential component of the mouse cardiac response to load-induced stress. J Clin Invest (2010) 1.25
Tumor vasculature-targeted delivery of tumor necrosis factor-alpha. Cancer (2009) 1.25
Discovery of a functional protein complex of netrin-4, laminin gamma1 chain, and integrin alpha6beta1 in mouse neural stem cells. Proc Natl Acad Sci U S A (2009) 1.24